Reagent Kit for Detection of SARS-CoV-2 RNA Using Real-Time Reverse Transcription PCR (RT-PCR-RV-SARS-CoV-2) According to TU 20.59.52-001-97313483-2020, Batch 220420

This reagent kit is intended for the detection of SARS-CoV-2 RNA using real-time reverse transcription polymerase chain reaction (RT-PCR-RV-SARS-CoV-2) and complies with the standard TU 20.59.52-001-97313483-2020.

I. RNA Extraction Reagent Kit

Available configuration: "M-Sorb-OOM-96"

Lysis Solution (LR), 50 ml – 1 bottle
Sorption Solution (SR), 6 ml – 1 bottle
Precipitation Solution (PR), 40 ml – 1 bottle
Wash Solution (WR), 50 ml – 1 bottle
Elution Solution (ER), 15 ml – 1 bottle
Internal Positive Extraction Control (IPE-RNA), 1 ml – 1 tube
Negative Extraction Control Sample (NEC), 5 ml – 1 bottle

II. RT-PCR-RV Assay Reagent Kit

Available configuration: "RT-PCR-RV-SARS-CoV-2"

Reaction Mix (PC-SARS-CoV-2), 1.5 ml – 1 tube
Internal Positive Control for Reverse Transcription (IPC-RT), 0.02 ml – 1 tube
Enzyme Mix (RPol), 0.02 ml – 1 tube
Positive Control Sample (PCS-nCoV) – 1 tube
Dilution Buffer for PCS (NEC), 1 ml – 1 tube

III. Instructions for Use

The kit includes detailed instructions for proper application.

IV. Reagent Kit Certificate

A certificate is included to confirm compliance and batch information.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Detection of SARS-CoV-2 RNA Using Real-Time Reverse Transcription PCR (RT-PCR-RV-SARS-CoV-2) According to TU 20.59.52-001-97313483-2020, Batch 220420, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Back